4 Mg Zoledronic Acid Injection IP
4 Mg Zoledronic Acid Injection IP

4 Mg Zoledronic Acid Injection IP

Price 499 INR/ Vial

MOQ : 1 Vial

4 Mg Zoledronic Acid Injection IP Specification

  • Salt Composition
  • Zoledronic Acid 4 mg
  • Dosage Form
  • Injection (Lyophilized Powder for Solution)
  • Indication
  • Treatment of osteoporosis, Pagets disease, hypercalcemia of malignancy, bone metastases
  • Feature
  • Single-dose vial, potent bisphosphonate for bone disorders
  • Ingredients
  • Zoledronic Acid, Mannitol, Sodium Citrate
  • Application
  • Intravenous administration
  • Ph Level
  • Adjusted to appropriate pharmaceutical standards (usually around 4.5-5.5 for infusion)
  • Physical Color/Texture
  • White to off-white lyophilized powder
  • Fermentation Smell
  • Odorless
  • Storage Instructions
  • Store below 25C, protect from light, do not freeze
  • Shelf Life
  • 24 months from manufacturing date
 
 

About 4 Mg Zoledronic Acid Injection IP



Experience the ultimate care in bone health with our 4 Mg Zoledronic Acid Injection IP. Crafted as a radiant, potent bisphosphonate, this affordable solution comes in a single-dose vial with instant checkout available for seamless procurement. Featuring 4 mg zoledronic acid as a commanding ingredient, the lyophilized powder is odorless with a white to off-white hue. Designed for intravenous infusion, it treats osteoporosis, Paget's disease, bone metastases, and hypercalcemia of malignancy. Each batch complies with rigorous IP standards, ensuring high safety, efficacy, and traceability. Hydration and renal function monitoring are advised.

How to Use and Key Features of 4 Mg Zoledronic Acid Injection IP

For optimal effectiveness, reconstitute the single-dose vial with 5 ml sterile water, as directed. Administer intravenously after further dilution in 100 ml of 0.9% sodium chloride or 5% dextrose, strictly over a minimum of 15 minutes. This commanding medication addresses osteoporosis, Paget's disease, bone metastases, and hypercalcemia related to malignancy. Odorless and featuring a white to off-white lyophilized powder, the injection assures pharmaceutical-grade precision and robust stabilization for single-use application.


Supply, Outlay, Payment & Certifications for Global Dispatch

With a reliable dispatching process, our capability as a prominent distributor, exporter, supplier, and trader ensures prompt delivery of 4 Mg Zoledronic Acid Injection IP across India and global destinations. Outlay terms are competitive, supporting a wide spectrum of payment options for ease of transaction. Every batch is dispatched under strict regulatory approvals, upholding IP certification, and includes batch and expiry information on the label for complete traceability throughout the supply chain.


FAQ's of 4 Mg Zoledronic Acid Injection IP:


Q: How is the 4 Mg Zoledronic Acid Injection IP administered?

A: The injection is prepared by dissolving the lyophilized powder in 5 ml sterile water, then further diluted in 100 ml of 0.9% sodium chloride or 5% dextrose and administered intravenously over at least 15 minutes.

Q: What conditions does this injection specifically treat?

A: It is indicated for osteoporosis, Paget's disease of bone, bone metastases, and hypercalcemia of malignancy, offering potent support in bone health management.

Q: When should hydration and renal monitoring be performed?

A: Patients should be adequately hydrated before administration, and renal function should be monitored both prior to and after the infusion, especially in those with pre-existing renal impairment.

Q: Where can I verify batch number, barcode, and expiry details?

A: All critical information, including batch number, expiry date, and a scannable barcode, is printed on the vial label and packaging for transparency and compliance.

Q: What are the main precautions and possible side effects?

A: Contraindicated during pregnancy, lactation, and severe renal issues, the injection may cause flu-like symptoms, bone or joint pain, nausea, or headache. Always administer under medical supervision.

Q: What compliance standards and certifications does this product meet?

A: Each vial complies with Indian Pharmacopoeia (IP) standards, and is dispatched with necessary regulatory authorizations as per country-specific requirements, ensuring safety and quality.

Tell us about your requirement
product

Price:

Quantity
Select Unit

  • 50
  • 100
  • 200
  • 250
  • 500
  • 1000+
Additional detail
Mobile number

Email

More Products in Anti Cancer Injection Category

4000 IU-Ml Erythropoietin Injection

4000 IU-Ml Erythropoietin Injection

Price 800 INR / Vial

Minimum Order Quantity : 1 Vial

Indication : Anemia associated with chronic renal failure, chemotherapy, or HIV therapy

Shelf Life : 24 months from manufacturing

Dosage Form : Injection

Salt Composition : Erythropoietin 4000 IU/mL

500 Mg 50 Ml Rituximab

500 Mg 50 Ml Rituximab

Price 5999 INR / Vial

Minimum Order Quantity : 1 Vial

Indication : NonHodgkins Lymphoma, Chronic Lymphocytic Leukemia, Rheumatoid Arthritis

Shelf Life : 24 Months

Dosage Form : Injection

Salt Composition : Rituximab 500 mg

15 Units Bleomycin For Injection USP

15 Units Bleomycin For Injection USP

Price 550 INR / Vial

Minimum Order Quantity : 1 Vial

Indication : Used for the treatment of various cancers including Hodgkins lymphoma, squamous cell carcinoma, testicular cancer, pleural effusions due to malignancy, and others

Shelf Life : Typically 24 months from the date of manufacture under recommended storage conditions

Dosage Form : Injection, Lyophilized Powder for Reconstitution

Salt Composition : Bleomycin (15 Units) USP

300 Mg - 12 Ml Bevacizumab Injection

300 Mg - 12 Ml Bevacizumab Injection

Price 10000 INR / Vial

Minimum Order Quantity : 1 Vial

Indication : Cancer Treatment (Colorectal Cancer, Lung Cancer, Renal Cell Carcinoma, Glioblastoma)

Shelf Life : 24 months from manufacturing date

Dosage Form : Injection

Salt Composition : Bevacizumab (300mg) per 12ml vial



Back to top